Retrospective Study
Copyright ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Aug 21, 2020; 26(31): 4694-4702
Published online Aug 21, 2020. doi: 10.3748/wjg.v26.i31.4694
Clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan
Hu Zhang, Yu-Sheng Liao, Jing Gong, Jing Liu, Heng Zhang
Hu Zhang, Yu-Sheng Liao, Jing Gong, Jing Liu, Heng Zhang, Department of Gastroenterology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430014, Hubei Province, China
Author contributions: Zhang H designed this study and critically revised the manuscript; Zhang H, Gong J, and Liu J were responsible for data acquisition and extraction; Zhang H and Zhang H drafted the manuscript, analyzed the data, and interpreted the results; Gong J and Liao YS were involved in editing the manuscript; all authors read and approved the final manuscript to be published.
Supported by the Health and Family Planning Commission of Wuhan, No. WX18Y04.
Institutional review board statement: This study was reviewed and approved by the Ethics Committee of the Central Hospital of Wuhan.
Informed consent statement: The Ethics Committee of the Central Hospital of Wuhan waived the informed consent statement.
Conflict-of-interest statement: We have no financial relationships to disclose.
Data sharing statement: No additional data are available.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Heng Zhang, MA, MD, Chief Doctor, Department of Gastroenterology, the Central Hospital of Wuhan, Tongji Medical College, Huazhong University of Science and Technology, No. 26 Shengli Street, Jiang’an District, Wuhan 430014, Hubei Province, China. 497697662@qq.com
Received: May 9, 2020
Peer-review started: May 9, 2020
First decision: June 13, 2020
Revised: June 20, 2020
Accepted: July 30, 2020
Article in press: July 30, 2020
Published online: August 21, 2020
Processing time: 104 Days and 2.7 Hours
ARTICLE HIGHLIGHTS
Research background

Coronavirus disease 2019 (COVID-19), an emerging infectious respiratory disease, has become a worldwide pandemic. The clinical features of COVID-19 are complicated and varied. In addition to lung injury, liver injury has been reported to occur during the course of the disease[1-3]. Similarly, previous studies have shown that patients infected by severe acute respiratory syndrome coronavirus and Middle East respiratory syndrome coronavirus may develop different degrees of liver injury. Nevertheless, the specific mechanism of liver injury is not clear.

Research motivation

COVID-19 has become a worldwide pandemic. We investigated the clinical characteristics of and risk factors for liver injury in COVID-19 patients in Wuhan by retrospectively analyzing the epidemiological, clinical, and laboratory data for 218 COVID-19 patients and identifying risk factors for liver injury by multivariate analysis.

Research objectives

To investigate the clinical characteristics and risk factors for liver injury in COVID-19 patients in Wuhan.

Research methods

The 218 patients included 94 males (43.1%), aged 22 to 94 (50.1 ± 18.4) years. Elevated aspartate aminotransferase (AST) and alanine aminotransferase (ALT) were present in 42 (53.2%) and 36 (45.6%) cases, respectively, and 79 (36.2%) patients had abnormally elevated transaminase levels at admission. Patients with liver injury were older than those with normal liver function by a median of 12 years, with a significantly higher frequency of males (68.4% vs 28.8%, P < 0.001) and more coexisting illnesses (48.1% vs 27.3%, P = 0.002). Significantly more patients had fever and shortness of breath (87.3% vs 69.8% and 29.1% vs 14.4%, respectively) in the liver injury group.

Research results

The early stage of COVID-19 may be associated with mildly elevated aminotransferase levels in patients in Wuhan. Male sex and high D-dimer level and neutrophil percentage may be important predictors of liver injury in patients with COVID-19.

Research conclusions

Male sex and high D-dimer level and neutrophil percentage may be important predictors of liver injury in patients with COVID-19.

Research perspectives

While further studies are needed to clarify these findings, they will provide reference for the management and treatment of liver injury in patients with COVID-19.